CD8A and cancer: Following activation by antigen-presenting cells and recognition of specific MHC-I-peptide complexes by the TCR, naive CD8+ T cells in conjunction with costimulatory signaling are activated and differentiate into cytotoxic effector T cells that are then able to target and destroy cells (e.g., infected cells, cancer cells) and secrete cytokines [17].